A practical and ethical solution to the opioid scheduling conundrum

Michael E Schatman1 Foundation for Ethics in Pain Care, Bellevue, WA, USACorrespondence[email protected]

Beth D Darnall2 Stanford University School of Medicine, Division of Pain Medicine, Palo Alto, CA, USA

Pages 1-3 | Published online: 06 Dec 2013

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

KatzNAbuse-deterrent opioid formulations: are they a pipe dream?Curr Rheumatol Rep200810111818457606
PubMedGoogle Scholar
TurkDCO’ConnorABDworkinRHResearch design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendationsPain20121531997200822770841
PubMed Web of Science ®Google Scholar
MichnaEChengWYCorvesCSystematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain managementPain Med9232013 [Epub ahead of print.]
Web of Science ®Google Scholar
CiceroTJEllisMSSurrattHLEffect of abuse-deterrent formulation of OxyContinN Engl J Med201236718718922784140
PubMed Web of Science ®Google Scholar
ButlerSFCassidyTAChilcoatHAbuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatmentJ Pain20131435135823127293
PubMed Web of Science ®Google Scholar
SevertsonSGBartlesonBBDavisJMReduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010J Pain2013141122113023816949
PubMed Web of Science ®Google Scholar
CoplanPMKaleHSandstromLLandauCChilcoatHDChanges in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristicsPharmacoepidemiol Drug Saf201322121274128224123484
PubMed Web of Science ®Google Scholar
VosburgSKJonesJDManubayJMAssessment of a formulation designed to be crush-resistant in prescription opioid abusersDrug Alcohol Depend201212620621522721679
PubMed Web of Science ®Google Scholar
VosburgSKJonesJDManuabayJMA comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusersAddiction20131081095110623316699
PubMed Web of Science ®Google Scholar
ManchikantiLFellowsBAilinaniHTherapeutic use, abuse, and nonmedical use of opioids: a ten-year perspectivePain Physician20101340143520859312
PubMed Web of Science ®Google Scholar
DarnallBDSchatmanMEArgoffCEBallantyneJCUnderstanding opioids: part 1Medscape Neurology192013 Available from: http://www.medscape.com/viewarticle/777126Accessed December 2, 2013
Google Scholar
BannwarthBWill abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?Drugs2012721713172322931520
PubMed Web of Science ®Google Scholar
FredericksonPDCriminal marketing: corporate and managerial liability in the prescription drug industryMidwest Law J200822115147
Google Scholar
OkieSA flood of opioids, a rising tide of deathsN Engl J Med20103631981198521083382
PubMed Web of Science ®Google Scholar
SchatmanMEThe role of the health insurance industry in perpetuating suboptimal pain management: ethical implicationsPain Med20111241542621332933
PubMed Web of Science ®Google Scholar
HartrickGTGatchelRJConroySIdentification and management of pain medication abuse and misuse: current state and future directionsExpert Rev Neurother20121260161022550988
PubMed Web of Science ®Google Scholar
HardenRNChronic pain and opiates: a call for moderationArch Phys Med Rehabil200889Suppl 1S72S7618295654
PubMed Web of Science ®Google Scholar
US Food and Drug AdministrationControlled Substances Act Available from: http://www.fda.gov/RegulatoryInformation/Legislation/ucm148726.htmAccessed October 31, 2013
Google Scholar
US Department of Justice Drug Enforcement AdministrationDrugs of Abuse, 2011 ed Available from: http://www.justice.gov/dea/docs/drugs_of_abuse_2011.pdfAccessed November 3, 2013
Google Scholar
MehendaleAWGoldmanMPMehendaleRPRanaKOpioids: myth versus reality, calling all physiciansJ Palliat Care Med20133151
Google Scholar
GudinJLeeAJThe downside of upschedulingPain Med2013141628162924238353
PubMed Web of Science ®Google Scholar
Centers for Disease Control and PreventionOpioids continue to be associated with an increase in drug overdose deaths2202013 Available from: http://www.cdc.gov/media/releases/2013/p0220_drug_overdose_deaths.htmlAccessed November 3, 2013
Google Scholar
von GuntenCFBrueraEPirrelloRDPortenoyRKNew opioids: expensive distractions or important additions to practice?J Palliat Med20101350551120406105
PubMed Web of Science ®Google Scholar
MastropietroDJOmidianHCurrent approaches in tamper-resistant and abuse-deterrent formulationsDrug Dev Ind Pharm20133961162422537282
PubMed Web of Science ®Google Scholar
ArgoffCEStanosSPWiemanMSValidity testing of patient objections to acceptance of tamper-resistant opioid formulationsJ Pain Res2013636737323696714
PubMed Web of Science ®Google Scholar
BrushwoodDBRichBAColemanJJLegal liability perspectives on abuse-deterrent opioids in the treatment of chronic painJ Pain Palliat Care Pharmacother20102433334821133741
PubMedGoogle Scholar
LourençoLMMatthewsMJamisonRNAbuse-deterrent and tamper-resistant opioids: how valuable are novel formulations in thwarting non-medical use?Expert Opin Drug Deliv20131022924023252692
PubMed Web of Science ®Google Scholar
StanosSPBruckenthalPBarkinRLStrategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tamperingMayo Clin Proc20128768369422766088
PubMed Web of Science ®Google Scholar
United NationsReport of the International Narcotics Control Board for 2012 Available from: https://www.incb.org/incb/en/publications/annual-reports/annual-report-2012.htmlAccessed November 3, 2013
Google Scholar
TobinCLDobbinMMcAvoyBRegulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United KingdomAust N Z J Public Health20132548348824090333
PubMed Web of Science ®Google Scholar
World Health OrganizationWHO’s pain ladder for adults Available from: http://www.who.int/cancer/palliative/painladder/en/Accessed November 15, 2013
Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A practical and ethical solution to the opioid scheduling conundrum

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A practical and ethical solution to the opioid scheduling conundrum

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date